Detalhe da pesquisa
1.
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study.
Anticancer Drugs
; 31(8): 856-865, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32639280
2.
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 19(9): 1215-1228, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115596
3.
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
Int J Cancer
; 142(5): 1047-1055, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29047142
4.
Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
Int J Cancer
; 140(8): 1918-1925, 2017 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28032641
5.
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer.
Anticancer Drugs
; 28(7): 717-722, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28582279
6.
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: a subgroup analysis from AIO-PK0104.
Acta Oncol
; 54(7): 993-1000, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924969
7.
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
BMC Cancer
; 14: 624, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25164437
8.
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany.
Oncol Res Treat
; 47(4): 123-134, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325341
9.
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212).
Clin Cancer Res
; 30(7): 1256-1263, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289994
10.
Early tumor shrinkage in metastatic colorectal cancer: retrospective analysis from an irinotecan-based randomized first-line trial.
Cancer Sci
; 104(6): 718-24, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23480146
11.
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
J Clin Oncol
; 41(25): 4143-4153, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352476
12.
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).
J Clin Oncol
; 41(16): 2975-2987, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018649
13.
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh®TM) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer.
Curr Oncol
; 30(6): 5828-5834, 2023 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366919
14.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Hemasphere
; 7(7): e904, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37427146
15.
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110).
Eur J Cancer
; 173: 194-203, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940054
16.
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
J Clin Oncol
; 40(1): 72-82, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34533973
17.
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.
Cancers (Basel)
; 14(3)2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158793
18.
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
Front Oncol
; 12: 751453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251955
19.
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study.
Cancer Med
; 10(22): 8127-8137, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668662
20.
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.
J Clin Oncol
; 39(13): 1468-1478, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764808